Metabolic bone disease occurring in individuals with chronic liver disease, known as hepatic osteodystrophy, is a potential complication of long-standing hepatic disease. Special care is required to prevent the development of fractures in individuals with advanced hepatic disease and following liver transplantation. This position statement summarizes the graded findings and recommendations of a systematic technical review of osteoporosis in these states. The general biology and pathogenesis of osteoporosis, including its relationship with inflammatory states, diagnostic tools, and clinical utility of bone densitometry, has been reviewed elsewhere in the AGA Technical Review on Osteoporosis in Gastrointestinal Diseases.
美国胃肠病学会医学:肝病患者的骨质疏松
发布日期:2003-09-01
英文标题:American Gastroenterological Association Medical Position Statement: Osteoporosis in Hepatic Disorders
来源:Gastroenterology, 2003, 125(3): 937-940
阅读次数:496